Is Reglan (metoclopramide) appropriate for an 11‑year‑old child, and what is the recommended dosage?

Metoclopramide (Reglan) Use in 11-Year-Old Children

Metoclopramide can be used in an 11-year-old child at a dose of 0.1 mg/kg orally every 6 hours (maximum 10 mg per dose), but treatment should not exceed 12 weeks and should be reserved for specific indications such as chemotherapy-induced nausea/vomiting or diabetic gastroparesis, not routine gastroesophageal reflux. 1

Approved Indications and Dosing

FDA-Approved Dosing for Adults

• Gastroesophageal reflux: 10-15 mg orally up to 4 times daily, 30 minutes before meals and at bedtime 1
• Diabetic gastroparesis: 10 mg orally 30 minutes before each meal and at bedtime for 2-8 weeks 1
• Maximum treatment duration: 12 weeks 1

Pediatric Dosing Evidence

• Recommended dose: 0.1 mg/kg orally every 6 hours based on pharmacokinetic modeling that achieves therapeutic exposure while minimizing toxicity risk 2
• For an 11-year-old with average weight (~35-40 kg), this translates to approximately 3.5-4 mg per dose, well below the adult maximum of 10 mg 2
• Alternative dosing for chemotherapy-induced nausea: 1-2 mg/kg IV has been studied, though higher doses (2 mg/kg) carry significantly increased risk of extrapyramidal reactions 3, 4

Safety Profile in Pediatric Patients

Common Adverse Effects

• Extrapyramidal symptoms (EPS): 9% incidence in pediatric studies, including acute dystonic reactions and akathisia 5
• Diarrhea: 6% incidence 5
• Sedation: 6% incidence with multiple-dose regimens 5

Critical Safety Considerations

• Age-related risk: Younger patients have increased susceptibility to acute extrapyramidal reactions compared to older adults 4
• Dose-dependent toxicity: At doses ≥2 mg/kg, 15% experienced EPRs and 33% had akathisia 4
• Consecutive day dosing: Increases frequency of extrapyramidal reactions 4
• Tardive dyskinesia risk: Overall risk is low (0.1% per 1000 patient-years), but pediatric-specific data are limited 6
• Despite the risk of dose-dependent tardive dyskinesia, expert consensus allows for more aggressive rounding (up to 10% dose variation) in clinical practice 7

Protective Measures

• Concomitant diphenhydramine: Should be administered to reduce incidence of extrapyramidal reactions 3, 4
• Dystonic reactions: Rapidly reversible with diphenhydramine if they occur 3

Clinical Context and Appropriate Use

When to Use Metoclopramide in Children

• Chemotherapy-induced nausea/vomiting: Demonstrated efficacy with 43-70% of patients experiencing fewer than 5 vomiting episodes 4
• Acute gastroenteritis with persistent vomiting: 72% cessation of vomiting achieved (comparable to ondansetron at 81%) 8
• Diabetic gastroparesis: FDA-approved indication, though pediatric data are limited 1

When NOT to Use Metoclopramide

• Routine gastroesophageal reflux in infants/children: Insufficient evidence of efficacy despite common off-label use 1, 2
• Age <1 year: Contraindicated by Canadian and EU regulatory agencies 5
• Prolonged therapy beyond 12 weeks: Not evaluated and cannot be recommended 1

Practical Prescribing Algorithm for an 11-Year-Old

1. Verify indication: Confirm appropriate use (chemotherapy-induced nausea, diabetic gastroparesis, or refractory vomiting)
2. Calculate dose: 0.1 mg/kg orally every 6 hours (approximately 3.5-4 mg for typical 11-year-old) 2
3. Co-prescribe diphenhydramine: To prevent extrapyramidal reactions 3, 4
4. Timing: Administer 30 minutes before meals and at bedtime 1
5. Duration limit: Do not exceed 12 weeks of continuous therapy 1
6. Monitor for EPS: Watch for dystonia, akathisia, or other movement disorders, especially in first 24-48 hours 5, 4
7. Avoid consecutive multi-day high-dose regimens: Higher risk of neurological complications 4

Key Pitfalls to Avoid

• Do not use 2 mg/kg dosing outside of acute chemotherapy settings with close monitoring, as this dramatically increases EPS risk to 15-33% 4
• Do not prescribe for routine pediatric GERD without documented failure of other therapies, as efficacy is not established 1, 2
• Do not continue beyond 12 weeks without reassessing need and considering alternative therapies 1
• Do not forget diphenhydramine prophylaxis when using metoclopramide in children 3, 4